Tablets
Anti-inflammatory / Analgesic / Antipyretic

Composition:
Active ingredient: Each tablet contains 7.5 mg or 15 mg of Meloxicam BP.
Inactive ingredients: Lactose, Hypromellose, Microcrystalline Cellulose,
Sodium Starch Glycolate, Colloidal Anhydrous Silica and Magnesium Stearate

Contraindications:
Neoxicam is contraindicated in patients with known hypersensitivity to
meloxicam or one of other components. It should not be used in patients
with asthma, nasal polyps, angioedema or urticaria following the administration
of acetyl salicylic acid or other NSAIDs. Neoxicam should not be used in
patients with active peptic ulcer, severe hepatic insufficiency and
non-dialysed renal insufficiency. Neoxicam should not be used in children
and adolescents aged less than 15 years. Neoxicam is contraindicated in
gastrointestinal bleeding, cerebrovascular bleeding or other bleeding
disorders.
Precautions:
Since Neoxicam metabolites are excreted in urine, patients with renal
impairment must be closely monitored. Neoxicam should be used with
caution in patients with hypertension or CHF due to risk of fluid retention
and oedema.

Dosage:
The lowest dose of Neoxicam should be sought for each patient. For
treatment of rheumatoid arthritis and ankylosing spondylitis, a starting dose
of 15 mg once daily is recommended. Dose may be reduced to 7.5 mg once
daily depending on therapeutic response. For treatment of osteoarthritis, a
starting dose of 7.5 mg once daily is recommended which may be increased
to 15 mg once daily. Maximum recommended daily dose is 15 mg. The daily
dose should be taken with a liquid during a meal

Side Effects:
Digestive system: Dyspepsia, nausea, vomiting, abdominal pain,
constipation, flatulence, diarrhoea, stomatitis, oesophagitis. Rarely, peptic
ulcers, gastrointestinal bleeding may occur, especially in the elderly.
Haematological system: Disturbances in the blood count such as anaemia,
leucocytopenia, thrombocytopenia have been reported. Agranulocytosis
has been reported rarely in patients who are also on a concomitant therapy with other potentially myelotoxic drugs.
Cutaneous reactions include pruritus, skin rash, urticaria and photosensitivity
reactions. Rare effects include erythema multiforme, Stevens-Johnson
syndrome and toxic epidermal necrolysis.
Hypersensitivity reactions have been reported. Anaphylactic reactions and
angioedema have been reported rarely.
Onset of asthma attacks have been reported in those individuals who are
allergic to aspirin or other NSAIDs.
CNS side effects include lightheadedness, headache, vertigo, tinnitus,
drowsiness. Confusion, mood disorders, insomnia and nightmares have
been reported rarely. Blurred vision has been reported rarely.
Oedema, oedema of the lower limbs, increase in blood pressure,
palpitations and flushes may occur.
When patients are on meloxicam therapy, there is a possibility of disturbances
of laboratory tests related to renal function such as raised creatinine or
urea and transitory disturbances of liver function tests such as raised
transaminases or bilirubin.
Rare cases of hepatitis have been reported.
Use in Pregnancy and Lactation:
Neoxicam is contraindicated in pregnancy and lactation.

Storage:
Store in a dry place below 25°C.

Presentation:
Packs of 10, 30 and 100 tablets.